The global 3D bio-printing market is poised for significant expansion, with projections indicating a rise from an ...

Winston-Salem has become a hot bed of science research and innovation, particularly in the medical field.

A new study has shed light on the challenges of converting one type of specialized cell into another, a process critical for ...

Is there anything between life and death? Apparently, yes, according to the latest research.

Shareholders approve name change and rebranding to Centenara Labs AG (“Centenara”) Rebrand positions business for strategic initiatives designed to support development of therapies for regenerative ...

Dr. Nguyen Thuy Ba Linh, a biomaterials researcher from Vietnam, has been recognized at the prestigious TechWomen 100 awards for her outstanding contributions and leadership in advancing biomaterials ...

The european platelet rich plasma (PRP) market is witnessing remarkable growth with forecasts predicting the market will ...

IRVINE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Octane, an innovative organization building the SoCal of Tomorrow by connecting people, resources and capit ...

The therapy is currently in Phase I/Ib clinical development for patients with relapsed/refractory multiple myeloma.

Exciting advancements in gene therapy at Ocugen with Phase 3 trials for retinitis pigmentosa and FDA approval goal by 2026.